Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase 1/2 13Phase 1 6Phase NA 5Phase 4 4Phase 3 2Phase 2/3 1

Status

Unknown 5Not yet recruiting 5Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2CNS 1

Conditions

Carcinoma, Hepatocellular 2Recurrence 1Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder) 1Liver Neoplasms 1Glioblastoma 1Adenocarcinoma of Lung 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Unknown × tislelizumab × Clear all
NCT06154967 2023-12-04

To Explore the Effect of Immune-induced Stereotactic Body Radiotherapy (SBRT) on Reversing Immunoresistance in Stage IIIc/IV Non-small Cell Lung Cancer (NSCLC)

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase NA Unknown
20 enrolled
Thoracic

Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

Guangzhou Institute of Respiratory Disease

Phase NA Unknown
28 enrolled
Thoracic

Adenocarcinoma of Lung

NCT05811793 2023-04-13

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Second Affiliated Hospital of Nanchang University

Phase NA Unknown
36 enrolled
CNS

Glioblastoma

NCT05339581 2022-04-27

iPLENTY-pvtt

RenJi Hospital

Phase NA Unknown
78 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05277675 2022-03-14

RANT

Southwest Hospital, China

Phase NA Unknown
160 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡